• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮细胞锚定的组织因子途径抑制剂调节小鼠肿瘤向肺的转移。

Endothelial cell-anchored tissue factor pathway inhibitor regulates tumor metastasis to the lung in mice.

作者信息

Wang Jiping, Xiao Jiajun, Wen Danping, Wu Xie, Mao Zuohua, Zhang Jin, Ma Duan

机构信息

Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, School of Basic Medical Sciences, Collaborative Innovation Center of Genetics and Development, Fudan University, Shanghai, China.

Department of Parasitology and Microbiology, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

Mol Carcinog. 2016 May;55(5):882-96. doi: 10.1002/mc.22329. Epub 2015 May 6.

DOI:10.1002/mc.22329
PMID:25945811
Abstract

Tissue factor pathway inhibitor (TFPI) is a physiological inhibitor of the tissue factor (TF)-initiated coagulation pathway. Both circulating and tumor cell-associated TFPI significantly reduce tumor cell-induced coagulation activation and lung metastasis. However, the significance of endothelial cell-anchored TFPI in cancer biology remains largely unexplored. We generated mice with full-length disruption of TFPI (including TFPIα and TFPIβ isoforms) in endothelial cells, using a Cre-LoxP system and gene inactivation (GI) strategy. Experimental pulmonary tumor metastasis models were used with TFPI-deficient mice to evaluate the role of endothelial cell-anchored TFPI in cancer progression. Finally, lung microvascular permeability and microenvironment were investigated. TFPI-deficient mice were viable and fertile, and showed decreased plasma TFPI levels and lung TFPI levels as compared with their control littermates. TFPI deficiency in endothelial cells promoted pulmonary tumor metastasis with an increased vascular permeability and altered lung microenvironment. Our observations suggest that endothelial cell-anchored TFPI controls lung tumor metastasis, and does so largely through the inhibition of local TF-induced thrombin generation and the regulation of the lung microenvironment in mice.

摘要

组织因子途径抑制物(TFPI)是组织因子(TF)启动的凝血途径的生理性抑制物。循环中的TFPI和肿瘤细胞相关的TFPI均能显著降低肿瘤细胞诱导的凝血激活及肺转移。然而,内皮细胞锚定的TFPI在癌症生物学中的意义在很大程度上仍未被探索。我们利用Cre-LoxP系统和基因失活(GI)策略,构建了内皮细胞中TFPI全长缺失(包括TFPIα和TFPIβ亚型)的小鼠。使用TFPI缺陷小鼠的实验性肺肿瘤转移模型来评估内皮细胞锚定的TFPI在癌症进展中的作用。最后,研究了肺微血管通透性和微环境。TFPI缺陷小鼠存活且可育,与对照同窝小鼠相比,其血浆TFPI水平和肺TFPI水平降低。内皮细胞中的TFPI缺陷通过增加血管通透性和改变肺微环境促进了肺肿瘤转移。我们的观察结果表明,内皮细胞锚定的TFPI控制肺肿瘤转移,并且在很大程度上是通过抑制局部TF诱导的凝血酶生成以及调节小鼠的肺微环境来实现的。

相似文献

1
Endothelial cell-anchored tissue factor pathway inhibitor regulates tumor metastasis to the lung in mice.内皮细胞锚定的组织因子途径抑制剂调节小鼠肿瘤向肺的转移。
Mol Carcinog. 2016 May;55(5):882-96. doi: 10.1002/mc.22329. Epub 2015 May 6.
2
Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.与凝血启动因子组织因子(TF)相反,凝血抑制剂组织因子途径抑制物(TFPI)的肿瘤表达、血浆水平及基因多态性与乳腺癌的临床病理参数及生存情况相关。
Breast Cancer Res. 2015 Mar 26;17(1):44. doi: 10.1186/s13058-015-0548-5.
3
Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.乙酰肝素酶诱导内皮细胞和肿瘤细胞中组织因子途径抑制物的表达及细胞外积聚。
Thromb Haemost. 2008 Jan;99(1):133-41.
4
TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.组织因子途径抑制物α和β在乳腺癌细胞表面表达并抑制 TF-FVIIa 活性。
J Hematol Oncol. 2013 Jan 15;6:5. doi: 10.1186/1756-8722-6-5.
5
Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells.Syndecan-3和组织因子途径抑制物(TFPI)在内皮细胞、平滑肌细胞和癌细胞表面共定位。
PLoS One. 2015 Jan 24;10(1):e0117404. doi: 10.1371/journal.pone.0117404. eCollection 2015.
6
Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.蛋白 S 是血小板和血管内皮组织因子途径抑制剂-α的辅助因子,但不是细胞表面相关组织因子途径抑制剂的辅助因子。
Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):169-76. doi: 10.1161/ATVBAHA.113.302655. Epub 2013 Nov 14.
7
Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma.组织因子途径抑制剂可减少B16黑色素瘤的实验性肺转移。
Thromb Haemost. 2002 Jun;87(6):930-6.
8
Structure and biology of tissue factor pathway inhibitor.组织因子途径抑制剂的结构与生物学特性
Thromb Haemost. 2001 Oct;86(4):959-72.
9
Deletion of tissue factor pathway inhibitor isoform beta or gamma, but not alpha, improves clotting in hemophilic mice.组织因子途径抑制物异构体β或γ缺失,而非α缺失,可改善血友病小鼠的凝血功能。
J Thromb Haemost. 2024 Oct;22(10):2681-2691. doi: 10.1016/j.jtha.2024.06.006. Epub 2024 Jun 24.
10
The role of tissue factor pathway inhibitor in tumor growth and metastasis.组织因子途径抑制剂在肿瘤生长和转移中的作用。
Semin Thromb Hemost. 2007 Oct;33(7):643-52. doi: 10.1055/s-2007-991531.

引用本文的文献

1
Non-Anticoagulant Heparin: An In Vitro Investigation of a Novel Therapeutic Approach for Oral Cancer.非抗凝肝素:口腔癌新型治疗方法的体外研究
Oral Dis. 2025 Jun;31(6):1672-1683. doi: 10.1111/odi.15288. Epub 2025 Mar 3.
2
TFPI from erythroblasts drives heme production in central macrophages promoting erythropoiesis in polycythemia.红细胞来源的 TFPI 驱动中巨噬细胞的血红素生成,从而促进红细胞生成增多症中的红细胞生成。
Nat Commun. 2024 May 10;15(1):3976. doi: 10.1038/s41467-024-48328-8.
3
Convergence of coronary artery disease genes onto endothelial cell programs.
冠状动脉疾病相关基因汇聚到内皮细胞程序中。
Nature. 2024 Feb;626(8000):799-807. doi: 10.1038/s41586-024-07022-x. Epub 2024 Feb 7.
4
ZNF354C Mediated by DNMT1 Ameliorates Lung Ischemia-Reperfusion Oxidative Stress Injury by Reducing TFPI Promoter Methylation to Upregulate TFPI.DNMT1 介导的 ZNF354C 通过减少 TFPI 启动子甲基化来上调 TFPI,从而减轻肺缺血再灌注氧化应激损伤。
Oxid Med Cell Longev. 2022 Jul 19;2022:7288729. doi: 10.1155/2022/7288729. eCollection 2022.
5
Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy.组织因子途径抑制剂对凝血的调节:对血友病治疗的影响。
J Thromb Haemost. 2022 Jun;20(6):1290-1300. doi: 10.1111/jth.15697. Epub 2022 Mar 27.
6
Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.重新评估小鼠组织因子途径抑制剂并比较小鼠和人组织因子途径抑制剂的生理学特性。
J Thromb Haemost. 2018 Nov;16(11):2246-2257. doi: 10.1111/jth.14288. Epub 2018 Oct 22.
7
Knockdown of TFPI-Anchored Endothelial Cells Exacerbates Lipopolysaccharide-Induced Acute Lung Injury Via NF-κB Signaling Pathway.TFPI 锚定内皮细胞敲低通过 NF-κB 信号通路加重脂多糖诱导的急性肺损伤。
Shock. 2019 Feb;51(2):235-246. doi: 10.1097/SHK.0000000000001120.
8
PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by regulating synaptic transmission in cerebellum.PRRT2 缺乏通过调节小脑突触传递诱导发作性运动诱发性运动障碍。
Cell Res. 2018 Jan;28(1):90-110. doi: 10.1038/cr.2017.128. Epub 2017 Oct 20.
9
Endogenous tissue factor pathway inhibitor in vascular smooth muscle cells inhibits arterial thrombosis.血管平滑肌细胞中的内源性组织因子途径抑制剂抑制动脉血栓形成。
Front Med. 2017 Sep;11(3):403-409. doi: 10.1007/s11684-017-0522-y. Epub 2017 May 27.
10
Targeting clotting proteins in cancer therapy - progress and challenges.癌症治疗中针对凝血蛋白——进展与挑战
Thromb Res. 2016 Apr;140 Suppl 1(Suppl 1):S1-7. doi: 10.1016/S0049-3848(16)30090-1.